Solvay Pharmaceuticals, Inc. announced that a new analysis of pivotal study data conducted by the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center showed that initial treatment response of hypogonadal men with AndroGel(R) (testosterone gel) 1% CIII had similar effects on subjects, regardless of weight and body mass index (BMI).
By the time you're done with this area you should accept a acceptable abstraction of the science abaft abscess and feel assured in how you would like to proceed.
Wednesday, June 18, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment